Evidence map›Paper›PMID 33113383›Full record

ArticleBiosensors & bioelectronics2021

One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device.

Liping Huang, Longfei Ding, Jun Zhou, Shuiliang Chen, Fang Chen, Chen Zhao, Jianqing Xu, Wenjun Hu, Jiansong Ji, Hao Xu and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Biosensors & bioelectronics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liping HuangNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luo Yu Road, Wuhan, 430074, PR China; Liangzhun (Shanghai) Industrial Co. Ltd, Shanghai, China. Electronic address: lphuang@aliyun.com.
Longfei DingShanghai Public Health Clinical Center, Fudan University, China.
Jun ZhouWuhan Xinxin Semiconductor Manufacturing Co. Ltd, Wuhan, China.
Shuiliang ChenTaiwan Semiconductor Manufacturing Co., Shanghai, China.
Fang ChenTaiwan Semiconductor Manufacturing Co., Shanghai, China.
Chen ZhaoShanghai Public Health Clinical Center, Fudan University, China.
Jianqing XuShanghai Public Health Clinical Center, Fudan University, China.
Wenjun HuNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luo Yu Road, Wuhan, 430074, PR China.
Jiansong JiLishui Central Hospital, Zhejiang University, Zhejiang, China.
Hao XuLiangzhun (Shanghai) Industrial Co. Ltd, Shanghai, China. Electronic address: billxu@kaizzi.com.
Gang L LiuNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luo Yu Road, Wuhan, 430074, PR China. Electronic address: loganliu@hust.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of SARS-CoV-2 virus in the ongoing global pandemic has led to infections of millions of people and losses of many lives. The rapid, accurate and convenient SARS-CoV-2 virus detection is crucial for controlling and stopping the pandemic. Diagnosis of patients in the early stage infection are so far limited to viral nucleic acid or antigen detection in human nasopharyngeal swab or saliva samples. Here we developed a method for rapid and direct optical measurement of SARS-CoV-2 virus particles in one step nearly without any sample preparation using a spike protein specific nanoplasmonic resonance sensor. As low as 370 vp/mL were detected in one step within 15 min and the virus concentration can be quantified linearly in the range of 0 to 10

Indexed as

Clinical Laboratory TechniquesPoint-of-Care TestingAntibodies, ImmobilizedBetacoronavirusBiosensing TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingEquipment DesignHumansLimit of DetectionModels, MolecularPandemicsPneumonia, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ImmobilizedSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibody conjugationCOVID-19Nanoplasmonic sensorPoint of care testingSARS-CoV-2 virus

Identifiers

PMID33113383
PMCPMC7557276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.